[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354010-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354010-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","novel-soat-inhibitors-block-dheas-transport-and-suppress-proliferation-in-mcf-7-breast-cancer-cells","Novel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells","","Intracrine estrogen production from adrenal precursors such as DHEAS supports proliferation of ER-positive breast cancer cells, yet the role of SOAT inhibition in this metabolism is unclear. Pharmacological inhibition of the SOAT transporter (SLC10A6) was tested in SOAT-overexpressing MCF-7 cells (MCF-7_SOAT) using S1647 and two new selective derivatives (12 and 24). DHEAS uptake and steroid metabolism were quantified by LC–MS/MS, and DHEAS-driven proliferation was assessed via [³H]thymidine incorporation. SOAT inhibition markedly reduced sodium-dependent DHEAS uptake, lowered intracellular estradiol synthesis, and suppressed estrogen-dependent proliferation without cytotoxicity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-soat-inhibitors-block-dheas-transport-and-suppress-proliferation-in-mcf-7-breast-cancer-cells/354010/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-soat-inhibitors-block-dheas-transport-and-suppress-proliferation-in-mcf-7-breast-cancer-cells/354010.png","ImageObject",300,407,{"name":42,"@type":43},"Riley West","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is SOAT important for DHEAS-related intracrine estrogen production in breast cancer cells?","Question",{"text":63,"@type":64},"SOAT (SLC10A6) transports sulfated steroids such as DHEAS into cells, providing precursors for local estrogen biosynthesis that sustains ER-positive tumor proliferation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the effects of SOAT inhibition on DHEAS transport and proliferation measured?",{"text":68,"@type":64},"DHEAS uptake and downstream steroid metabolism were quantified using LC–MS/MS, and DHEAS-induced cell proliferation was analyzed by [³H]thymidine incorporation.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the overall effect of SOAT inhibitors on MCF-7_SOAT cells?",{"text":72,"@type":64},"SOAT inhibitors strongly reduced sodium-dependent DHEAS uptake, decreased intracellular estradiol synthesis, and suppressed estrogen-dependent proliferation without causing cytotoxicity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354010,1790181818,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNovel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells  \nEmre Karakus1􀀍, Silke Leiting1, Michael Daude2, Wibke E. Diederich2 & Joachim Geyer1  \nIntracrine estrogen formation from adrenal precursors such as dehydroepiandrosterone sulfate (DHEAS) plays a critical role in sustaining estrogen receptor (ER)-positive breast cancer cell proliferation, particularly in postmenopausal women. The sodium-dependent organic anion transporter (SOAT, gene symbol SLC10A6) facilitates the cellular uptake of sulfated steroids, thereby making these precursors available for local estrogen biosynthesis. However, the impact of SOAT inhibition on intracrine estrogen metabolism in breast cancer remains unclear. We investigated the effects of pharmacological SOAT inhibition on SOAT-mediated DHEAS transport, cell proliferation and intracrine estradiol synthesis in SOAT-overexpressing MCF-7 breast cancer cells (MCF-7_SOAT). These MCF- 7_SOAT cells were treated with the SOAT inhibitor S1647, as well as two newly synthesized derivatives (compounds 12 and 24) that exhibit enhanced selectivity and potency. DHEAS uptake and downstream steroid metabolism were quantified using LC–MS/MS, while DHEAS-induced cell proliferation was analyzed using [³H]thymidine incorporation. SOAT inhibition markedly reduced sodium-dependent DHEAS uptake, resulting in decreased intracellular estradiol synthesis and suppression of estrogendependent proliferation without cytotoxicity. These findings confirm that SOAT is a critical upstream regulator of intracrine estrogen biosynthesis in breast cancer cells and highlight compounds 12 and 24 as promising candidates for further preclinical development aimed at reducing local estrogen production.  \nKeywords SOAT (SLC10A6), DHEAS transport, Intracrine estrogen formation, MCF-7 cells, Breast cancer, Endocrine therapy  \nBreast cancer remains the most frequently diagnosed malignancy and the leading cause of cancer-related death among women worldwide1. In 2018, an estimated two million new cases were reported globally, with the majority occurring in postmenopausal women, and a substantial proportion resulting in mortality2. It is estimated that 70–80% of breast cancers are estrogen receptor (ER)-positive, in which tumor cell proliferation is promoted by estrogens, making the ER pathway a major therapeutic target in breast cancer management3–5. In premenopausal women, estrogens are primarily synthesized in the ovaries. After menopause, systemic estrogen levels decline sharply due to the loss of ovarian function. However, peripheral estrogen formation continues and partially compensates for this deficiency, helping to sustain several beneficial estrogen-dependent physiological functions6. Local estrogen production in postmenopausal women mainly occurs in peripheral tissues, such as adipose tissue, skin, and mammary glands via the sulfatase and aromatase pathways starting from sulfated steroid precursors such as estrone sulfate (E1S) and dehydroepiandrosterone sulfate (DHEAS)7–11.  \nSeveral studies have demonstrated a strong association between circulating steroid hormones and breast cancer risk. Hankinson et al.12 reported that case subjects had significantly higher plasma levels of estrone (E1), estradiol (E2), E1S, and DHEAS compared with controls. DHEAS is particularly noteworthy, because it circulatesat concentrations 100,000–200,000 times higher than E213, and women with DHEAS levels in the upper three quartiles show a higher risk of developing breast cancer compared with those in the lowest quartile12, 14. Kalogera  \n1Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Biomedical Research Center Seltersberg (BFS), Justus Liebig University of Giessen, Schubertstr. 81, 35392 Giessen, Germany. 2Fachbereich Pharmazie, Institut für Pharmazeutische Chemie und Zentrum für Tumor und Immunbiologie, Phi","cbCaiqKaF02p8SRj","https://ap.wps.com/l/cbCaiqKaF02p8SRj","pdf",1697662,11,"English","# Introduction\n## Intracrine estrogen formation and SOAT function\n## Breast cancer, ER positivity, and postmenopausal estrogen pathways\n## Evidence linking steroid hormones and DHEAS to breast cancer risk\n# Study rationale and approach\n## Pharmacological SOAT inhibition in MCF-7_SOAT cells","[{\"question\":\"Why is SOAT important for DHEAS-related intracrine estrogen production in breast cancer cells?\",\"answer\":\"SOAT (SLC10A6) transports sulfated steroids such as DHEAS into cells, providing precursors for local estrogen biosynthesis that sustains ER-positive tumor proliferation.\"},{\"question\":\"How were the effects of SOAT inhibition on DHEAS transport and proliferation measured?\",\"answer\":\"DHEAS uptake and downstream steroid metabolism were quantified using LC–MS/MS, and DHEAS-induced cell proliferation was analyzed by [³H]thymidine incorporation.\"},{\"question\":\"What was the overall effect of SOAT inhibitors on MCF-7_SOAT cells?\",\"answer\":\"SOAT inhibitors strongly reduced sodium-dependent DHEAS uptake, decreased intracellular estradiol synthesis, and suppressed estrogen-dependent proliferation without causing cytotoxicity.\"}]","Novel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells | PDF",1790108454,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f94a8c1cceb052385630a3b42dd263f0.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/816aab87606cfb5e1334e9e4b441bf29.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9d003b48e381a2b33718347ddcc4623.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8b10cea7a49c57b449d5e6575a0697c.webp",980,1287]